133 related articles for article (PubMed ID: 38032439)
1. The 3
Juhlin CC; Baloch ZW
Endocr Pathol; 2024 Mar; 35(1):77-79. PubMed ID: 38032439
[No Abstract] [Full Text] [Related]
2. [On-site fine-needle aspiration cytology of thyroid nodules. Quality assurance of the Bethesda System for Reporting Thyroid Cytopathology (2008)].
Bak M; Péter I; Nyári T; Simon P; Újlaky M; Boér A; Kásler M
Orv Hetil; 2015 Oct; 156(41):1661-6. PubMed ID: 26551169
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.
Wong LQ; Baloch ZW
Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380
[TBL] [Abstract][Full Text] [Related]
4. Application of the Bethesda system for reporting thyroid cytopathology for classification of thyroid nodules: A clinical and cytopathological characteristics in Bhutanese population.
Choden S; Wangmo C; Maharjan S
Diagn Cytopathol; 2021 Nov; 49(11):1179-1187. PubMed ID: 34320270
[TBL] [Abstract][Full Text] [Related]
5. Current issues in fine needle aspiration biopsy of thyroid gland.
Dušková J
Cesk Patol; 2019; 55(1):13-23. PubMed ID: 30939883
[TBL] [Abstract][Full Text] [Related]
6. Impact of the 3rd Edition of the Bethesda System for Reporting Thyroid Cytopathology on Grey Zone Categories.
Guerreiro SC; Tastekin E; Mourao M; Loureiro I; Eusebio R; Marques HP; Oznur M; Caliskan CK; Schmitt FC; Bongiovanni M; Canberk S
Acta Cytol; 2023; 67(6):593-603. PubMed ID: 37899024
[TBL] [Abstract][Full Text] [Related]
7. The 2023 Bethesda System for Reporting Thyroid Cytopathology.
Ali SZ; Baloch ZW; Cochand-Priollet B; Schmitt FC; Vielh P; VanderLaan PA
Thyroid; 2023 Sep; 33(9):1039-1044. PubMed ID: 37427847
[TBL] [Abstract][Full Text] [Related]
8. [Bethesda 2023: A new terminology for thyroid cytopathology].
Cochand-Priollet B; Vielh P
Ann Pathol; 2024 Feb; 44(1):30-35. PubMed ID: 38233236
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound Parameters of Thyroid Nodules and the Risk of Malignancy: A Retrospective Analysis.
Wang M; Sun P; Zhao X; Sun Y
Cancer Control; 2020; 27(1):1073274820945976. PubMed ID: 33035078
[TBL] [Abstract][Full Text] [Related]
10. Bethesda System Categories of Fine Needle Aspiration Cytology Are Not Associated with Thyroid Nodule Location: A Single Institution Experience.
Xavier-Júnior JCC; Abrantkoski Borges F; Pizzello Zogheib RJ; Camilo-Júnior DJ
Acta Cytol; 2021; 65(1):22-26. PubMed ID: 32877898
[TBL] [Abstract][Full Text] [Related]
11. The Impact of the 2022 WHO Classification of Thyroid Neoplasms on Everyday Practice of Cytopathology.
Rossi ED; Baloch Z
Endocr Pathol; 2023 Mar; 34(1):23-33. PubMed ID: 36797454
[TBL] [Abstract][Full Text] [Related]
12. Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.
Manning AM; Yang H; Falciglia M; Mark JR; Steward DL
Otolaryngol Head Neck Surg; 2017 Apr; 156(4):611-615. PubMed ID: 28118554
[TBL] [Abstract][Full Text] [Related]
13. Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses.
Rossi M; Lupo S; Rossi R; Franceschetti P; Trasforini G; Bruni S; Tagliati F; Buratto M; Lanza G; Damiani L; Degli Uberti E; Zatelli MC
Endocrine; 2017 Jul; 57(1):98-107. PubMed ID: 27623969
[TBL] [Abstract][Full Text] [Related]
14. Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.
Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Zhou F; Simsir A; Sheth S; Brandler TC
Cancer Cytopathol; 2020 Jul; 128(7):470-481. PubMed ID: 32078249
[TBL] [Abstract][Full Text] [Related]
15. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
[TBL] [Abstract][Full Text] [Related]
16. [Interpretation of the third edition Bethesda system for reporting thyroid cytopathology].
Jiao Q; Liu ZY
Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(41):3238-3244. PubMed ID: 37926565
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of fine needle aspiration cytology in pediatric thyroid nodules based on Bethesda Classification.
Jiang W; Phillips SA; Newbury RO; Naheedy JH; Newfield RS
J Pediatr Endocrinol Metab; 2021 Apr; 34(4):449-455. PubMed ID: 33629571
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of cytomorphology of thyroid lesion on conventional cytology versus liquid-based cytology and categorize the lesions according to The Bethesda System for Reporting Thyroid Cytopathology.
Alam MQ; Pandey P; Ralli M; Singh Chauhan JP; Aggarwal R; Chaturvedi V; Kapoor A; Trivedi K; Agarwal S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S259-S266. PubMed ID: 36510974
[TBL] [Abstract][Full Text] [Related]
19. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
[TBL] [Abstract][Full Text] [Related]
20. A comparative study between conventional and the Bethesda System for Reporting Thyroid Cytology of 240 cases.
Pandey P; Dixit A; Sawhney A; Ralli M; Chaturvedi V; Agarwal S; Singh JP; Gupta S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S253-S258. PubMed ID: 36510973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
